4-Chloro-3-(4-cyclopropylbenzyl)-1-(6-deoxy-6-{[methoxy(oxo)acetyl]amino}-beta-D-glucopyranosyl)-1H-indole

ID: ALA3786347

Chembl Id: CHEMBL3786347

PubChem CID: 127034238

Max Phase: Preclinical

Molecular Formula: C27H29ClN2O7

Molecular Weight: 528.99

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)C(=O)NC[C@H]1O[C@@H](n2cc(Cc3ccc(C4CC4)cc3)c3c(Cl)cccc32)[C@H](O)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C27H29ClN2O7/c1-36-27(35)25(34)29-12-20-22(31)23(32)24(33)26(37-20)30-13-17(21-18(28)3-2-4-19(21)30)11-14-5-7-15(8-6-14)16-9-10-16/h2-8,13,16,20,22-24,26,31-33H,9-12H2,1H3,(H,29,34)/t20-,22-,23+,24-,26-/m1/s1

Standard InChI Key:  UZDYFYYKVXSYFM-DNMDETFRSA-N

Alternative Forms

  1. Parent:

    ALA3786347

    ---

Associated Targets(Human)

SLC5A1 Tclin Sodium/glucose cotransporter 1 (1526 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC5A2 Tclin Sodium/glucose cotransporter 2 (2000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 528.99Molecular Weight (Monoisotopic): 528.1663AlogP: 2.03#Rotatable Bonds: 6
Polar Surface Area: 130.25Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.60CX Basic pKa: CX LogP: 3.41CX LogD: 3.41
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.28Np Likeness Score: 0.23

References

1. Chu KF, Yao CH, Song JS, Chen CT, Yeh TK, Hsieh TC, Huang CY, Wang MH, Wu SH, Chang WE, Chao YS, Lee JC..  (2016)  N-Indolylglycosides bearing modifications at the glucose C6-position as sodium-dependent glucose co-transporter 2 inhibitors.,  24  (10): [PMID:27075813] [10.1016/j.bmc.2016.03.058]

Source